Remus Pharmaceuticals fundamental analysis
REMUS
706
22.00 (3.22%)Last updated on 13 Jan, 2026 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Remus Pharmaceuticals Fundamentals
P/E Ratio
28.56
P/B Ratio
3.17
Div. Yield
0.11
Sector P/E
39.44
Sector P/B
2.52
Sec. Div. Yield
85.01
Remus Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 28.56, compared to the sector average of 39.44. Its P/B Ratio stands at 3.17, while the sector’s is 2.52. In terms of returns, the stock offers a Dividend Yield of 0.11%, which is than the sector’s 85.01%.
Remus Pharmaceuticals Score Card
Price
Attractive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Remus Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
